- Investing Ideas
- Polish Pharmaceuticals & Biotech Top Stock Picks from Analysts
Polish Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
4
Companies which are more than 50% undervalued based on analyst price target.
4 companies
Selvita
Market Cap: zł554.3m
Provides drug discovery, drug development, and contract testing services in Poland.
SLV
zł30.20
7D
-3.8%
1Y
6.0%
Ryvu Therapeutics
Market Cap: zł354.2m
A clinical-stage drug discovery and development company, engages in developing of small molecule therapies for treatment in oncology in Poland, European Union, and internationally.
RVU
zł15.32
7D
1.1%
1Y
-50.3%
Molecure
Market Cap: zł122.0m
A biotechnology company, engages in discovering, developing, and commercializing therapeutics for neoplastic and inflammatory diseases in Poland.
MOC
zł5.92
7D
-2.0%
1Y
3.9%
Poltreg
Market Cap: zł113.3m
A biotechnology company, researches and develops therapies for autoimmune diseases.
PTG
zł19.15
7D
4.1%
1Y
-39.6%